[Springer] Efficacy and safety of orforglipron 12mg versus orforglipron 36mg maintenance dose among patients with obesity with or without diabetes: a systematic review and comprehensive meta-analysis

dexter153 Post time 5 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-29 09:57
Reward10points

journalㄩBMC Endocrine Disorders

AuthorsㄩMohamed Gamal Hegaz; Mohammad Yassin Al Aboud; Abanoub I. I. Kamel; Muhammad Abdullah Naveed; Omar Gamal Elsayed; Aqsa Zoey Sorathia

Published dateㄩ--

DOIㄩ10.1186/s12902-026-02538-x

PDF linkㄩhttps://link.springer.com/article/10.1186/s12902-026-02538-x

Article linkㄩhttps://doi.org/10.1186/s12902-026-02538-x

Article SourceㄩSpringer Science and Business Media LLC﹝


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Victor90 Post time 5 hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    0

Return to the list